XOMA Corp (XOMA)
24.78
-0.66
(-2.59%)
USD |
NASDAQ |
May 03, 16:00
25.21
+0.43
(+1.74%)
After-Hours: 20:00
XOMA Free Cash Flow (Quarterly): -3.927M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.927M |
| September 30, 2023 | -2.099M |
| June 30, 2023 | -7.208M |
| March 31, 2023 | -4.924M |
| December 31, 2022 | -3.89M |
| September 30, 2022 | -3.663M |
| June 30, 2022 | -4.317M |
| March 31, 2022 | -1.009M |
| December 31, 2021 | 24.64M |
| September 30, 2021 | -10.08M |
| June 30, 2021 | -3.975M |
| March 31, 2021 | -14.41M |
| December 31, 2020 | 16.48M |
| September 30, 2020 | -2.445M |
| June 30, 2020 | -2.87M |
| March 31, 2020 | -2.28M |
| December 31, 2019 | -4.148M |
| September 30, 2019 | -9.201M |
| June 30, 2019 | -9.093M |
| March 31, 2019 | 2.857M |
| December 31, 2018 | -2.712M |
| September 30, 2018 | -17.75M |
| June 30, 2018 | -3.349M |
| March 31, 2018 | -3.839M |
| December 31, 2017 | -5.209M |
| Date | Value |
|---|---|
| September 30, 2017 | 30.64M |
| June 30, 2017 | -8.407M |
| March 31, 2017 | -14.35M |
| December 31, 2016 | 6.97M |
| September 30, 2016 | -12.04M |
| June 30, 2016 | -12.36M |
| March 31, 2016 | -16.32M |
| December 31, 2015 | 28.80M |
| September 30, 2015 | -19.09M |
| June 30, 2015 | -16.53M |
| March 31, 2015 | -24.50M |
| December 31, 2014 | -17.48M |
| September 30, 2014 | -15.95M |
| June 30, 2014 | -16.93M |
| March 31, 2014 | -28.25M |
| December 31, 2013 | -7.413M |
| September 30, 2013 | -13.04M |
| June 30, 2013 | -11.60M |
| March 31, 2013 | -15.03M |
| December 31, 2012 | -11.74M |
| September 30, 2012 | -12.14M |
| June 30, 2012 | -7.165M |
| March 31, 2012 | -12.22M |
| December 31, 2011 | -8.805M |
| September 30, 2011 | -7.975M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-14.41M
Minimum
Mar 2021
24.64M
Maximum
Dec 2021
-2.548M
Average
-3.927M
Median
Dec 2023
Free Cash Flow (Quarterly) Benchmarks
| Kinnate Biopharma Inc (DELISTED) | -17.36M |
| Societal CDMO Inc (DELISTED) | 0.793M |
| Corcept Therapeutics Inc | 5.887M |
| Sarepta Therapeutics Inc | -284.52M |
| AnaptysBio Inc | -34.63M |